AIDS Res Hum Retroviruses. 1994 Dec;10(12):1651-8.

A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

Purtscher M, Trkola A, Gruber G, Buchacher A, Predl R, Steindl F, Tauer C, Berger R, Barrett N, Jungbauer A, et al.

Source

Institute of Applied Microbiology, University of Agriculture, Vienna, Austria.

Abstract

We have established a hybridoma clone, designated 2F5, secreting a neutralizing human monoclonal antibody (MAb) specific for gp41 of human immunodeficiency virus type 1 (HIV-1). The epitope of MAb 2F5 was mapped to amino acid sequence Glu-Leu-Asp-Lys-Trp-Ala on the ectodomain of gp41. In this study different in vitro test systems were used to characterize the neutralizing properties of MAb 2F5. In syncytium inhibition assays, fusion inhibition experiments, and neutralization assays on different HIV-susceptible cells (H9, U937, and peripheral blood mononuclear cells) MAb 2F5 showed broad-spectrum neutralizing capacity against HIV-1 laboratory isolates IIIB, MN, RF, and SF2. In addition, primary isolates from AIDS patients were also neutralized.

PMID:: 7888224; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. [J Virol. 1993]
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1.
Muster T, Steindl F, Purtscher M, Trkola A, Klima A, Himmler G, Rüker F, Katinger H. J Virol. 1993 Nov; 67(11):6642-7.
A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates. [J Acquir Immune Defic Syndr Hum Retrovirol....]
A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates.
Cotropia J, Ugen KE, Kliks S, Broliden K, Broliden PA, Hoxie JA, Srikantan V, Williams WV, Weiner DB. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul; 12(3):221-32.
Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions. [AIDS Res Hum Retroviruses. 1995]
Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.
Neurath AR, Strick N, Lin K, Jiang S. AIDS Res Hum Retroviruses. 1995 Jun; 11(6):687-96.
Review Progress towards the development of a HIV-1 gp41-directed vaccine. [Curr HIV Res. 2004]
Review Progress towards the development of a HIV-1 gp41-directed vaccine.
McGaughey GB, Barbato G, Bianchi E, Freidinger RM, Garsky VM, Hurni WM, Joyce JG, Liang X, Miller MD, Pessi A, et al. Curr HIV Res. 2004 Apr; 2(2):193-204.
Review The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. [Microbiol Mol Biol Rev. 2008]
Review The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.
Montero M, van Houten NE, Wang X, Scott JK. Microbiol Mol Biol Rev. 2008 Mar; 72(1):54-84, table of contents.

See reviews... See all...

Cited by 69 PubMed Central articles

Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. [PLoS Pathog. 2011]
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.
Lai RP, Yan J, Heeney J, McClure MO, Göttlinger H, Luban J, Pizzato M. PLoS Pathog. 2011 Dec; 7(12):e1002442. Epub 2011 Dec 15.
Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles. [Virol J. 2011]
Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles.
Bridge SH, Sharpe SA, Dennis MJ, Dowall SD, Getty B, Anson DS, Skinner MA, Stewart JP, Blanchard TJ. Virol J. 2011 Sep 7; 8:429. Epub 2011 Sep 7.
Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge. [PLoS One. 2011]
Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge.
Borggren M, Repits J, Sterjovski J, Uchtenhagen H, Churchill MJ, Karlsson A, Albert J, Achour A, Gorry PR, Fenyö EM, et al. PLoS One. 2011; 6(6):e20135. Epub 2011 Jun 16.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A broadly neutralizing human monoclonal antibody against gp41 of human immunodef...
A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.
AIDS Res Hum Retroviruses. 1994 Dec ;10(12):1651-8.

PubMed
Bone marrow transplant in thalassemia. A role for radiation?
Bone marrow transplant in thalassemia. A role for radiation?
Ann N Y Acad Sci. 1998 Jun 30 ;850:503-5.

PubMed
The human mutator gene homolog MSH2 and its association with hereditary nonpolyp...
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.
Cell. 1993 Dec 3 ;75(5):1027-38.

PubMed
Pancreatic gene expression in rare cells of thymic medulla: evidence for functio...
Pancreatic gene expression in rare cells of thymic medulla: evidence for functional contribution to T cell tolerance.
Int Immunol. 1997 Sep ;9(9):1355-65.

PubMed
Long-term and high-temperature storage of supercritically-processed microparticu...
Long-term and high-temperature storage of supercritically-processed microparticulate protein powders.
Pharm Res. 1997 Oct ;14(10):1370-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

Source

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Cited by 69 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information